How Simpson was paid
$527,174 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Total |
|---|---|---|---|---|
| Andrew SimpsonPresident, Chief Executive Officer and Chairman of the Board of Directors | $345,833 | $65,000 | $116,341 | $527,174 |
| Mark HilzChief Operating Officer and Secretary | $337,879 | $65,000 | $116,341 | $519,220 |
| Danielle WatsonChief Financial Officer and Treasurer | $203,674 | $30,000 | $23,268 | $256,942 |
What changed and why
- $527KAndrew Simpson received total compensation of $527,174 for fiscal 2025, representing an increase from his prior year total of $300,000.
- $519KMark Hilz received total compensation of $519,220 for fiscal 2025, compared to $300,000 in the prior year.
- $257KDanielle Watson received total compensation of $256,942 for fiscal 2025, compared to $179,317 in the prior year.
- $116KOption awards for the CEO totaled $116,341 based on grant date fair value under FASB ASC Topic 718.
- The company granted additional RSUs and performance-based cash bonuses tied to FDA clearance milestones and change of control provisions.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.